🇺🇸 FDA
Pipeline program

Nalbuphine HCl solution

Protocol 1008910 (TR08)

Phase 1 small_molecule completed

Quick answer

Nalbuphine HCl solution for Nalbuphine is a Phase 1 program (small_molecule) at Trevi Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Trevi Therapeutics
Indication
Nalbuphine
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials